| 《中国药典》2020年版含黄芪成方制剂分析及其现代研究进展 |
| 投稿时间：2022-02-13 点此下载全文
|
| 引用本文：陶雨凡,董凡,兀琦,葛学丽,袁晓庆,宋书祎,杨爱琳,张加余.《中国药典》2020年版含黄芪成方制剂分析及其现代研究进展[J].中国现代中药,2023,25(1):202-209 |
| DOI：10.13313/j.issn.1673-4890.20220213001 |
| 摘要点击次数: 1330 |
| 全文下载次数: 137 |
| 作者中文名 | 作者英文名 | 单位中文名 | 单位英文名 | E-Mail |
| 陶雨凡 |
TAO Yu-fan |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 董凡 |
DONG Fan |
北京中医药大学 中药学院，北京 102488 |
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China. |
|
| 兀琦 |
WU Qi |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 葛学丽 |
GE Xue-li |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 袁晓庆 |
YUAN Xiao-qing |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 宋书祎 |
SONG Shu-yi |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 杨爱琳* |
YANG Ai-lin |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
| 张加余 |
ZHANG Jia-yu |
滨州医学院 药学院，山东 烟台 264003 |
School of Pharmacy, Binzhou Medical University, Yantai 264003, China |
|
|
| 基金项目:国家自然科学基金项目（82174039）；山东省自然科学基金项目（ZR2020MH371）；山东省泰山学者青年专家项目（tsqn202103110）；山东省青创人才引育计划项目（10073004）；山东省中药材及饮片标准研究项目（2020-201）；全国大学生创新创业训练计划项目（S202010440006）；山东省大学生创新创业训练计划项目（S202010440114S） |
|
| 中文摘要:通过查阅《中华人民共和国药典》（以下简称《中国药典》）2020年版（一部），统计其中收载的含黄芪成方制剂，归纳整理其中药味数、制剂剂型、功效主治、禁忌事项及主要药对，并对相关的临床应用和药理作用研究进行综述。结果发现，《中国药典》2020年版共收载了224种含黄芪的成方制剂，包括40种炙黄芪的成方制剂，处方用药味数以6~10味居多，制剂剂型以颗粒剂居多，功效主治以补益气血为主，禁忌事项则以孕妇禁忌居多。可为黄芪的临床新应用、新功效挖掘、新剂型改良及黄芪成方制剂的深度开发提供参考。 |
| 中文关键词:《中国药典》 黄芪 成方制剂 现代研究进展 |
| |
| Analysis and Modern Research Progress of Formulas Containing Astragali Radix in Chinese Pharmacopoeia (2020 Edition) |
|
|
| Abstract:Formulas containing Astragali Radix in Chinese Pharmacopoeia (2020 Edition) were statistically analyzed. To be specific, the number of medicinals in the formulas, the dosage forms, indications, contraindications, and the main medicinal pairs were summed up, and the clinical applications and pharmacological actions were reviewed. The results showed that Chinese Pharmacopoeia recorded 224 formulas containing Astragali Radix, with 40 containing Astragali Radix Preparata. The number of medicinals used in most of the formulas fell in the range of 6-10, and most the formulas were granules. Moreover, the majority of the formulas had the functions of tonifying and replenishing qi and blood with the taboo for pregnant women. To sum up, this review is expected to serve as a reference for the clinical application, exploration of novel functions, improvement of dosage form, and further development of Astragali Radix. |
| keywords:Chinese Pharmacopoeia Astragali Radix formulation progress in modern research |
|
查看全文
查看/发表评论 下载PDF阅读器 |
|
|
|
